1. Home
  2. BPTH
  3. BPTH News

Latest Bio-Path Holdings Inc. (BPTH) News on July 27, 2024

Bio-Path Holdings Provides Clinical Update and Expansion Plans
BPTH

GlobeNewswire

19 days ago

Bio-Path Holdings Provides Clinical Update and Expansion Plans

Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatment of Acute Myeloid Leukemia at European Hematology Association Congress
BPTH

GlobeNewswire

a month ago

Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatment of Acute Myeloid Leukemia at European Hematology Association Congress

Bio-Path Holdings Announces Closing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
BPTH

GlobeNewswire

2 months ago

Bio-Path Holdings Announces Closing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q1 24
BPTH

Newsfile

2 months ago

Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q1 24

Bio-Path Holdings Announces $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
BPTH

GlobeNewswire

2 months ago

Bio-Path Holdings Announces $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatment of Acute Myeloid Leukemia at American Society of Clinical Oncology (ASCO) Annual Meeting
BPTH

GlobeNewswire

2 months ago

Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatment of Acute Myeloid Leukemia at American Society of Clinical Oncology (ASCO) Annual Meeting

Bio-Path Holdings to Present Data at 2024 European Hematology Association Congress
BPTH

GlobeNewswire

2 months ago

Bio-Path Holdings to Present Data at 2024 European Hematology Association Congress

Bio-Path Holdings to Present Data at American Society of Clinical Oncology (ASCO) Annual Meeting
BPTH

GlobeNewswire

2 months ago

Bio-Path Holdings to Present Data at American Society of Clinical Oncology (ASCO) Annual Meeting

BPTH

GuruFocus.com

2 months ago

Bio-Path Holdings Inc (BPTH) Q1 2024 Earnings Call Transcript Highlights: Strategic Advances ...

BPTH

Thomson Reuters StreetEvents

2 months ago

Q1 2024 Bio Path Holdings Inc Earnings Call

BPTH

Associated Press Finance

2 months ago

Bio-Path: Q1 Earnings Snapshot

Bio-Path Holdings Reports First Quarter 2024 Financial Results
BPTH

GlobeNewswire

2 months ago

Bio-Path Holdings Reports First Quarter 2024 Financial Results

Bio-Path Holdings to Announce First Quarter 2024 Financial Results on May 15, 2024
BPTH

GlobeNewswire

3 months ago

Bio-Path Holdings to Announce First Quarter 2024 Financial Results on May 15, 2024

Bio-Path Holdings, Inc. Announces Closing of $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
BPTH

GlobeNewswire

3 months ago

Bio-Path Holdings, Inc. Announces Closing of $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Bio-Path (BPTH) Rises on Upbeat Updates From Blood Cancer Study
BPTH

Zacks

3 months ago

Bio-Path (BPTH) Rises on Upbeat Updates From Blood Cancer Study

Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
BPTH

GlobeNewswire

3 months ago

Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Bio-Path Holdings Announces Successful Completion of Higher Dose Second Cohort in Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia (AML) Patients
BPTH

GlobeNewswire

3 months ago

Bio-Path Holdings Announces Successful Completion of Higher Dose Second Cohort in Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia (AML) Patients

Bio-Path Holdings Expands Global Patent Portfolio
BPTH

GlobeNewswire

3 months ago

Bio-Path Holdings Expands Global Patent Portfolio

Bio-Path Holdings Provides 2024 Clinical and Operational Update
BPTH

GlobeNewswire

4 months ago

Bio-Path Holdings Provides 2024 Clinical and Operational Update

Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q4 23
BPTH

Newsfile

4 months ago

Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q4 23

Bio-Path Holdings, Inc. (NASDAQ:BPTH) Q4 2023 Earnings Call Transcript
BPTH

Insider Monkey

5 months ago

Bio-Path Holdings, Inc. (NASDAQ:BPTH) Q4 2023 Earnings Call Transcript

BPTH

Thomson Reuters StreetEvents

5 months ago

Q4 2023 Bio Path Holdings Inc Earnings Call

Bio-Path Holdings Reports Full Year 2023 Financial Results
BPTH

GlobeNewswire

5 months ago

Bio-Path Holdings Reports Full Year 2023 Financial Results

Bio-Path Holdings to Announce Fourth Quarter and Full Year 2023 Financial Results on March 8, 2024
BPTH

GlobeNewswire

5 months ago

Bio-Path Holdings to Announce Fourth Quarter and Full Year 2023 Financial Results on March 8, 2024

Bio-Path Holdings Announces 1-for-20 Reverse Stock Split
BPTH

GlobeNewswire

5 months ago

Bio-Path Holdings Announces 1-for-20 Reverse Stock Split

When Can We Expect A Profit From Bio-Path Holdings, Inc. (NASDAQ:BPTH)?
BPTH

Simply Wall St.

5 months ago

When Can We Expect A Profit From Bio-Path Holdings, Inc. (NASDAQ:BPTH)?

EXCLUSIVE: Orgenesis Acquires Control of Octomera, Takes One Step Closer To Progressing Its Decentralized Immuno-Oncology Portfolio To Clinic
BPTH

Benzinga

6 months ago

EXCLUSIVE: Orgenesis Acquires Control of Octomera, Takes One Step Closer To Progressing Its Decentralized Immuno-Oncology Portfolio To Clinic

Regis Corporation Reports Continued Profitability for the Second Fiscal Quarter 2024
BPTH

Business Wire

6 months ago

Regis Corporation Reports Continued Profitability for the Second Fiscal Quarter 2024

BPTH

Business Wire

6 months ago

Cyclo Therapeutics Announces Allowance of Patent Application for Treatment of Alzheimer’s Disease from the U.S. Patent and Trademark Office

Vicarious Surgical Strengthens Executive Team with Appointment of Randy Clark as Company President
BPTH

Business Wire

6 months ago

Vicarious Surgical Strengthens Executive Team with Appointment of Randy Clark as Company President

Alterity Therapeutics to Participate in the ShareCafe Hidden Gems Webinar This Week
BPTH

GlobeNewswire

6 months ago

Alterity Therapeutics to Participate in the ShareCafe Hidden Gems Webinar This Week

15 Cash-Rich Penny Stocks Hedge Funds Are Buying
BPTH

Insider Monkey

6 months ago

15 Cash-Rich Penny Stocks Hedge Funds Are Buying

Agri Supply Chooses Bridgeline’s AI-Powered Smart Search
BPTH

GlobeNewswire

6 months ago

Agri Supply Chooses Bridgeline’s AI-Powered Smart Search

Top Building Materials Retailer Contracts Bridgeline for AI-Powered SmartSearch
BPTH

GlobeNewswire

6 months ago

Top Building Materials Retailer Contracts Bridgeline for AI-Powered SmartSearch

When Will Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Become Profitable?
BPTH

Simply Wall St.

6 months ago

When Will Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Become Profitable?

Alterity Therapeutics Issues Shareholder Letter Highlighting Pipeline Advances and Key Upcoming Milestones
BPTH

GlobeNewswire

6 months ago

Alterity Therapeutics Issues Shareholder Letter Highlighting Pipeline Advances and Key Upcoming Milestones

PodcastOne (Nasdaq: PODC) Renews Agreement With Award Winning Our Fake History Podcast
BPTH

NewMediaWire

6 months ago

PodcastOne (Nasdaq: PODC) Renews Agreement With Award Winning Our Fake History Podcast

Trusted Choice Selects Bridgeline’s WooRank SEO Index
BPTH

GlobeNewswire

6 months ago

Trusted Choice Selects Bridgeline’s WooRank SEO Index

BPTH

Zacks Small Cap Research

6 months ago

CTSO: CytoSorbents reports update on data results from important U.S. and Canadian STAR-T pivotal trial.

Nukkleus Signs MOU to Substantially Increase Holdings in Jacobi Asset Management
BPTH

Business Wire

6 months ago

Nukkleus Signs MOU to Substantially Increase Holdings in Jacobi Asset Management

Groundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb® Intraoperatively in Heart Transplant Patients
BPTH

GlobeNewswire

6 months ago

Groundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb® Intraoperatively in Heart Transplant Patients

Altisource Asset Management Corporation Repurchases Preferred Shares in Global Settlement With Luxor Capital
BPTH

Business Wire

6 months ago

Altisource Asset Management Corporation Repurchases Preferred Shares in Global Settlement With Luxor Capital

Sotherly Hotels Inc. Schedules Fourth Quarter 2023 Earnings Release and Conference Call
BPTH

GlobeNewswire

6 months ago

Sotherly Hotels Inc. Schedules Fourth Quarter 2023 Earnings Release and Conference Call

ReWalk Robotics Ltd. to Present at Sidoti Virtual Investor Conference on January 17
BPTH

GlobeNewswire

6 months ago

ReWalk Robotics Ltd. to Present at Sidoti Virtual Investor Conference on January 17

Ekso Bionics Announces $4.6 Million Registered Direct Offering
BPTH

GlobeNewswire

6 months ago

Ekso Bionics Announces $4.6 Million Registered Direct Offering

Bio-Path Holdings Announces Completion of First Dose Cohort in Phase 1 Clinical Trial Evaluating BP1002 to Treat Refractory/Relapsed Lymphoma and Refractory/Relapsed Chronic Lymphocytic Leukemia Patients
BPTH

GlobeNewswire

7 months ago

Bio-Path Holdings Announces Completion of First Dose Cohort in Phase 1 Clinical Trial Evaluating BP1002 to Treat Refractory/Relapsed Lymphoma and Refractory/Relapsed Chronic Lymphocytic Leukemia Patients

Hycroft Delivers More High-Grade - Expands New Silver System at Brimstone
BPTH

PR Newswire

7 months ago

Hycroft Delivers More High-Grade - Expands New Silver System at Brimstone

Ekso Bionics Launches GaitCoach Software for EksoNR
BPTH

GlobeNewswire

7 months ago

Ekso Bionics Launches GaitCoach Software for EksoNR

Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms Guidance
BPTH

GlobeNewswire

7 months ago

Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms Guidance

First ReWalk Personal Exoskeleton Claim Paid by Medicare
BPTH

GlobeNewswire

7 months ago

First ReWalk Personal Exoskeleton Claim Paid by Medicare

Ekso Bionics Reports Certain Preliminary Fourth Quarter and Full Year 2023 Financial Results
BPTH

GlobeNewswire

7 months ago

Ekso Bionics Reports Certain Preliminary Fourth Quarter and Full Year 2023 Financial Results

Oncternal Therapeutics Announces Reverse Stock Split
BPTH

GlobeNewswire

7 months ago

Oncternal Therapeutics Announces Reverse Stock Split

ReWalk Robotics CEO Issues Year-End 2023 Open Letter to Shareholders and Provides 2024 Commercial and Operational Priorities
BPTH

GlobeNewswire

7 months ago

ReWalk Robotics CEO Issues Year-End 2023 Open Letter to Shareholders and Provides 2024 Commercial and Operational Priorities

Fenbo Holdings Limited Announces Appointment of Mr. Meng Derong as Co-Chairman and Independent Non-Executive Director
BPTH

GlobeNewswire

7 months ago

Fenbo Holdings Limited Announces Appointment of Mr. Meng Derong as Co-Chairman and Independent Non-Executive Director

Nukkleus Releases Updated Corporate Presentation: Lays Out Vision for Building Financial Infrastructure of the Future
BPTH

PR Newswire

7 months ago

Nukkleus Releases Updated Corporate Presentation: Lays Out Vision for Building Financial Infrastructure of the Future

Stronghold Announces Addition of up to ~1 EH/s Through Bitcoin Miner Purchases and an Option to Purchase Bitcoin Miners
BPTH

GlobeNewswire

7 months ago

Stronghold Announces Addition of up to ~1 EH/s Through Bitcoin Miner Purchases and an Option to Purchase Bitcoin Miners

BTC Digital Ltd. Announces Purchase of 2,000 Units of T21 Miners
BPTH

PR Newswire

7 months ago

BTC Digital Ltd. Announces Purchase of 2,000 Units of T21 Miners

Stronghold Digital Mining Inc CEO Gregory Beard Sells 38,759 Shares
BPTH

GuruFocus.com

7 months ago

Stronghold Digital Mining Inc CEO Gregory Beard Sells 38,759 Shares

Estimating The Fair Value Of Nukkleus Inc. (NASDAQ:NUKK)
BPTH

Simply Wall St.

7 months ago

Estimating The Fair Value Of Nukkleus Inc. (NASDAQ:NUKK)

Foremost Lithium Announces a 7,500 Metre Winter Drill Program on Its Zoro Lithium Property
BPTH

GlobeNewswire

7 months ago

Foremost Lithium Announces a 7,500 Metre Winter Drill Program on Its Zoro Lithium Property

CytoSorbents Provides Update on the STAR-T Trial and Reports Final Independent Data and Safety Monitoring Board Recommendation
BPTH

GlobeNewswire

7 months ago

CytoSorbents Provides Update on the STAR-T Trial and Reports Final Independent Data and Safety Monitoring Board Recommendation

BPTH

Business Wire

7 months ago

Cyclo Therapeutics, Inc. Completes Merger with Applied Molecular Transport Inc.

ASHFORD TRUST SETS FOURTH QUARTER EARNINGS RELEASE AND CONFERENCE CALL DATES
BPTH

PR Newswire

7 months ago

ASHFORD TRUST SETS FOURTH QUARTER EARNINGS RELEASE AND CONFERENCE CALL DATES

Trevena Inc. Announces $4 Million Concurrent Private Placement and Warrant Exercise
BPTH

GlobeNewswire

7 months ago

Trevena Inc. Announces $4 Million Concurrent Private Placement and Warrant Exercise

Fujian Blue Hat Interactive Entertainment Technology First Half 2023 Earnings: US$0.36 loss per share (vs US$1.02 loss in 1H 2022)
BPTH

Simply Wall St.

7 months ago

Fujian Blue Hat Interactive Entertainment Technology First Half 2023 Earnings: US$0.36 loss per share (vs US$1.02 loss in 1H 2022)

Oncternal Therapeutics Updates the Status of its Phase 1/2 Study of ONCT-808, a ROR1-Targeting Autologous CAR T, in Patients with Relapsed or Refractory Aggressive B-cell Lymphoma
BPTH

GlobeNewswire

7 months ago

Oncternal Therapeutics Updates the Status of its Phase 1/2 Study of ONCT-808, a ROR1-Targeting Autologous CAR T, in Patients with Relapsed or Refractory Aggressive B-cell Lymphoma

Stronghold Enters Into $15 Million Private Placement
BPTH

GlobeNewswire

7 months ago

Stronghold Enters Into $15 Million Private Placement

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q2 2024 Earnings Call Transcript
BPTH

Insider Monkey

7 months ago

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q2 2024 Earnings Call Transcript

BPTH

Business Wire

7 months ago

Cyclo Therapeutics Announces Positive Outcome from Type C Meeting with the U.S. FDA Discussing Trappsol® Cyclo™ Clinical Program for the Treatment of Niemann-Pick Disease Type C1

Insider Spends US$100k Buying More Shares In Cytosorbents
BPTH

Simply Wall St.

7 months ago

Insider Spends US$100k Buying More Shares In Cytosorbents

Rafael Holdings Reports First Quarter Fiscal 2024 Financial Results
BPTH

GlobeNewswire

7 months ago

Rafael Holdings Reports First Quarter Fiscal 2024 Financial Results

IPA Reports Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2024*
BPTH

Business Wire

7 months ago

IPA Reports Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2024*

Bio-Path Holdings Successfully Completes First Dose Cohort of Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia
BPTH

GlobeNewswire

7 months ago

Bio-Path Holdings Successfully Completes First Dose Cohort of Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia

BPTH

InvestorPlace

7 months ago

AMC Stock: This Dog With Fleas Just Won’t Die. Should You Buy? NO.

Milestone Scientific Inc. Announces Closing of $3.0 Million Public Offering of Common Stock
BPTH

GlobeNewswire

7 months ago

Milestone Scientific Inc. Announces Closing of $3.0 Million Public Offering of Common Stock

Milestone Scientific Inc. Announces Pricing of $3.0 Million Public Offering of Common Stock
BPTH

GlobeNewswire

8 months ago

Milestone Scientific Inc. Announces Pricing of $3.0 Million Public Offering of Common Stock

IPA Announces Closing of $1.265 Million Public Offering of Common Shares
BPTH

Business Wire

8 months ago

IPA Announces Closing of $1.265 Million Public Offering of Common Shares

Faraday Future Announces Upcoming FF 91 2.0 Deliveries, Including a B2B Co-Creation Partnership with Motev, LLC, a Leader in Luxury Sustainable Transportation, Founded by Robert Gaskill and Morgan Freeman
BPTH

Business Wire

8 months ago

Faraday Future Announces Upcoming FF 91 2.0 Deliveries, Including a B2B Co-Creation Partnership with Motev, LLC, a Leader in Luxury Sustainable Transportation, Founded by Robert Gaskill and Morgan Freeman

Altisource Asset Management Corporation Reports Key Ruling in Blackrock and PIMCO Litigation
BPTH

Business Wire

8 months ago

Altisource Asset Management Corporation Reports Key Ruling in Blackrock and PIMCO Litigation

Edgio’s Group Vice President of EMEA, Emma Whitmore, to Join the Digital TV Group (DTG) Council
BPTH

Business Wire

8 months ago

Edgio’s Group Vice President of EMEA, Emma Whitmore, to Join the Digital TV Group (DTG) Council

After Plunging -35.07% in 4 Weeks, Here's Why the Trend Might Reverse for Edgio (EGIO)
BPTH

Zacks

8 months ago

After Plunging -35.07% in 4 Weeks, Here's Why the Trend Might Reverse for Edgio (EGIO)

Hycroft Regains Compliance with Nasdaq Listing Requirements
BPTH

PR Newswire

8 months ago

Hycroft Regains Compliance with Nasdaq Listing Requirements

Edgio Announces New Board of Directors
BPTH

Business Wire

8 months ago

Edgio Announces New Board of Directors

ADIO and Faraday Future unleash generative AI and advanced EVs for Abu Dhabi's SAVI cluster
BPTH

Business Wire

8 months ago

ADIO and Faraday Future unleash generative AI and advanced EVs for Abu Dhabi's SAVI cluster

Fenbo Holdings Limited Announces Closing of Its Initial Public Offering
BPTH

GlobeNewswire

8 months ago

Fenbo Holdings Limited Announces Closing of Its Initial Public Offering

Fenbo Holdings Limited Announces Pricing of Its Initial Public Offering
BPTH

GlobeNewswire

8 months ago

Fenbo Holdings Limited Announces Pricing of Its Initial Public Offering

Ocuphire Pharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
BPTH

GlobeNewswire

8 months ago

Ocuphire Pharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Faraday Future Receives Over 300 No-Deposit Reservations for FF 91 2.0 aiFalcon within 72 hours Following the Success of its Middle East Strategy Press Conference and the Yas Marina Circuit Showcase at the Abu Dhabi Formula 1 Grand Prix
BPTH

Business Wire

8 months ago

Faraday Future Receives Over 300 No-Deposit Reservations for FF 91 2.0 aiFalcon within 72 hours Following the Success of its Middle East Strategy Press Conference and the Yas Marina Circuit Showcase at the Abu Dhabi Formula 1 Grand Prix

Ocuphire Pharma Announces Appointment of Joseph Schachle, M.B.A., as Chief Operating Officer
BPTH

GlobeNewswire

8 months ago

Ocuphire Pharma Announces Appointment of Joseph Schachle, M.B.A., as Chief Operating Officer

Genprex Granted Orphan Drug Designation in Small Cell Lung Cancer
BPTH

NewMediaWire

8 months ago

Genprex Granted Orphan Drug Designation in Small Cell Lung Cancer

Insider Spends US$59k Buying More Shares In Crown Crafts
BPTH

Simply Wall St.

8 months ago

Insider Spends US$59k Buying More Shares In Crown Crafts

TechPrecision Corporation Reports Second Quarter 2024 Financial Results
BPTH

ACCESSWIRE

8 months ago

TechPrecision Corporation Reports Second Quarter 2024 Financial Results

Bio-Path Holdings, Inc. (NASDAQ:BPTH) Q3 2023 Earnings Call Transcript
BPTH

Insider Monkey

8 months ago

Bio-Path Holdings, Inc. (NASDAQ:BPTH) Q3 2023 Earnings Call Transcript

Crown Crafts (NASDAQ:CRWS) Is Due To Pay A Dividend Of $0.08
BPTH

Simply Wall St.

8 months ago

Crown Crafts (NASDAQ:CRWS) Is Due To Pay A Dividend Of $0.08

With 51% ownership of the shares, Assertio Holdings, Inc. (NASDAQ:ASRT) is heavily dominated by institutional owners
BPTH

Simply Wall St.

8 months ago

With 51% ownership of the shares, Assertio Holdings, Inc. (NASDAQ:ASRT) is heavily dominated by institutional owners

BPTH

Zacks Small Cap Research

8 months ago

SDOT: Sadot Group reports 3rd quarter operating results which showed continued high levels of revenue generation in the core agri-foods subsidiary.

Crown Crafts, Inc. (NASDAQ:CRWS) Q2 2024 Earnings Call Transcript
BPTH

Insider Monkey

8 months ago

Crown Crafts, Inc. (NASDAQ:CRWS) Q2 2024 Earnings Call Transcript

RenovoRx Expands Scientific Advisory Board with Appointment of Michel Ducreux, M.D., Ph.D.
BPTH

Business Wire

8 months ago

RenovoRx Expands Scientific Advisory Board with Appointment of Michel Ducreux, M.D., Ph.D.

Vicarious Surgical to Present at the Piper Sandler 35th Annual Healthcare Conference
BPTH

Business Wire

8 months ago

Vicarious Surgical to Present at the Piper Sandler 35th Annual Healthcare Conference

BPTH

Associated Press Finance

8 months ago

Bio-Path: Q3 Earnings Snapshot

Share on Social Networks: